Two out of the four internationally-recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, according to new research presented at the European Emergency ...
Barcelona, Spain: Two out of the four internationally-recommended screening tools used by emergency medical services are inadequate for recognising sepsis, according to new research presented at the ...
In a recent study published in Scientific Reports, researchers evaluated the additional predictive value of molecular immune markers with the Predict Sepsis screening tools developed previously by the ...
The U.S. Food and Drug Administration (FDA) has approved an AI-powered early warning system to detect sepsis, one of the deadliest infections for hospital patients. The tool, developed at Johns ...
Please provide your email address to receive an email when new articles are posted on . Pregnancy-adjusted screening tools had high sepsis predictability rates for women with sepsis or ...
Measuring nitric oxide in patient breath might give clinicians a faster tool for screening for sepsis risks. “With sepsis, speed and accuracy can help save lives,” explains Tom Burke, CEO of Vail ...
Pediatric sepsis remains a leading cause of morbidity and mortality in children worldwide, characterised by dysregulated host response to infection leading to organ dysfunction. Early recognition, ...
Health experts have launched an online tool to help the public understand their risk of a potentially life-threatening condition. Sepsis occurs when the body’s immune system over-reacts to an ...
Health experts have launched an online tool designed to help the public understand their risk of sepsis. The potentially life-threatening condition occurs when the body’s immune system overreacts to ...
New retrospective study in CHEST found procalcitonin testing at admission reduced the length of stay and total cost of care Each year, over $20 billion dollars is spent on sepsis care, making it the ...
Both the diagnosis and management of infectious diseases in hospitalized patients remain prominent clinical challenges and are associated with a substantial financial burden for healthcare systems.